Articles From: Celebrity Chef Carla Hall to Host $1 Million 47th Pillsbury Bake-Off® Contest to Celladon Corporation Conducts Initial Scale Up of Manufacturing Process for MYDICAR to Commercial Scale


2014/10/27
The public will vote online to help determine the contest's $1 million grand prize winner, who will be announced on ABC's "The Chew" on December 3 MINNEAPOLIS , Oct.
Sign-up for Celebrity Chef Carla Hall to Host $1 Million 47th Pillsbury Bake-Off® Contest investment picks
Culinary Expert Visits Los Angeles on November 9 to Help Educate At-Risk Population About Ingredients for Successful Blood Sugar Management WHITEHOUSE STATION, N.J. , Nov.
Sign-up for Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal investment picks
2014/12/4
MIAMI , Dec.
Sign-up for Celebrity Cruises Orders Two New Iconic Ships investment picks
2014/10/29
Eleven one-of-a-kind vacation packages combine immersive European river cruises with modern luxury ocean sailings MIAMI , Oct.
Sign-up for Celebrity Cruises Takes European Vacations to New Heights with River-and-Ocean Cruise Vacations investment picks
2014/12/5
Photo and Video B-ROLL Opportunity WHO NICK CANNON, celebrity entertainer and author of the new children's holiday picture book, ROC & ROE'S TWELVE DAYS OF CHRISTMAS .
Sign-up for Celebrity Entertainer and Author NICK CANNON To Sign Copies of His New Children's Picture Book, ROC & ROE'S TWELVE DAYS OF CHRISTMAS Monday, December 8, 2014 at 12:00 Noon Barnes & Noble Fifth Avenue investment picks
With the support of more than 40 professional athletes and celebrities and DIAMOND RESORTS INTERNATIONAL® (NYSE:DRII), a global leader in the hospitality and vacation ownership industries, $805,000 in net proceeds were successfully raised to benefit the Walt Disney Pavilion at Florida Hospital for Children (FHFC) at the second annual Brian Gay Invitational at Mystic Dunes Resort & Golf Club in Celebration, Florida on December 12-14, 2014.
Sign-up for Celebrity Guests at Diamond Resorts International’s Brian Gay Invitational Help Raise $805,000 for Florida Hospital for Children investment picks
New varieties available for a limited time exclusively at Target stores BOULDER, Colo.
Sign-up for Celestial Seasonings® Announces Three Indulgent New Teas in Keepsake Gift Tins investment picks
2014/12/3
TORONTO , Dec.
Sign-up for Celestica Amends Normal Course Issuer Bid investment picks
2015/1/20
(All amounts in U.S. dollars.
Sign-up for Celestica Announces Fourth Quarter and Fiscal Year 2014 Financial Results investment picks
2015/1/20
Celestica Announces Fourth Quarter and Fiscal Year 2014 Financial Results Canada NewsWire (All amounts in U.S. dollars.
Sign-up for Celestica Announces Fourth Quarter and Fiscal Year 2014 Financial Results investment picks
TORONTO , Oct.
Sign-up for Celestica CEO Enters Automatic Securities Disposition Plan investment picks
2015/1/5
TORONTO , Jan.
Sign-up for Celestica Inc. - Q4 / 2014 Financial Results and Conference Call investment picks
Celgene Corporation (NASDAQ:CELG) provided a business update as well as its preliminary 2014 results and financial outlook for 2015 and beyond at the 33 rd Annual J.P. Morgan Healthcare Conference.
Sign-up for Celgene Corporation Announces 2015 and Long-Term Financial Outlook and Preliminary 2014 Results investment picks
2015/1/6
During the 33rd Annual J.P. Morgan Healthcare Conference on January 12, 2015 at 10:30 a.m. ET, Celgene Corporation (NASDAQ:CELG) will present a business update on the Company in addition to unaudited 2014 financial results and an updated financial outlook.
Sign-up for Celgene Corporation to Present at the 33rd Annual J.P. Morgan Healthcare Conference investment picks
Celgene Corporation (NASDAQ:CELG) plans to present at two upcoming investor conferences, where Celgene management will provide an overview of the Company, and at the 56th American Society of Hematology (ASH) annual meeting in December.
Sign-up for Celgene Corporation to Webcast at Upcoming Investor Conferences and Medical Congress investment picks
Celgene International Sàrl (NASDAQ: CELG), a wholly-owned subsidiary of Celgene Corporation, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for OTEZLA® (apremilast), the Company’s oral selective inhibitor of phosphodiesterase 4 (PDE4), in two therapeutic indications: 1 Psoriasis is an immune mediated skin condition characterised by raised scaly lesions on the skin.
Sign-up for Celgene Receives Positive CHMP Opinion for OTEZLA® (apremilast), the First Oral PDE4 Inhibitor for the Treatment of Patients with Psoriasis and Psoriatic Arthritis investment picks
Celgene International Sàrl, a wholly owned subsidiary of Celgene Corporation (NASDAQ: CELG), today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for continuous oral treatment with REVLIMID ® in adult patients with previously untreated multiple myeloma who are not eligible for stem cell transplantation.
Sign-up for Celgene Receives Positive CHMP Opinion to Extend REVLIMID® (Lenalidomide) for Continuous Use in Patients with Newly Diagnosed Multiple Myeloma and Ineligible for Transplant investment picks
Celgene Corporation (NASDAQ:CELG) received notice of an unsolicited “mini-tender” offer by TRC Capital Corporation to purchase up to 1,000,000 shares of Celgene’s common stock, approximately 0.13% of outstanding shares, at $101.75 per share.
Sign-up for Celgene Recommends Shareholders Reject “Mini-Tender” Offer by TRC Capital Corporation investment picks
Celgene Corporation (NASDAQ:CELG) reported net product sales of $1,957 million for the third quarter of 2014, a 19 percent increase from the same period in 2013.
Sign-up for Celgene Reports Third Quarter 2014 Operating and Financial Results investment picks
2015/1/12
By Angela Chen Celgene Corp.
Sign-up for Celgene Upbeat About Revlimid Sales But Warns on Currency Effects investment picks
Shares of Celgene Corp.
Sign-up for Celgene's stock rises, but off highs after profit outlook investment picks
http://media.marketwire.com/attachments/201411/291217_CellMedX_WhiteLogo_Small_FINAL.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1166702&ProfileId=051205&sourceType=1 LAS VEGAS, NV --
Sign-up for Cell MedX Corp. (CMXC) Announces Change of Auditors investment picks
http://media.marketwire.com/attachments/201411/291217_CellMedX_WhiteLogo_Small_FINAL.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1167306&ProfileId=051205&sourceType=1 LAS VEGAS, NV --
Sign-up for Cell MedX Corp. (CMXC) Announces Commencement of the Pilot Trial of Its e-balance Technology investment picks
http://media.marketwire.com/attachments/201411/291217_CellMedX_WhiteLogo_Small_FINAL.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1165849&ProfileId=051205&sourceType=1 LAS VEGAS, NV --
Sign-up for Cell MedX Corp. (CMXC) Announces the First Order Received by Its Newly Formed Wholly Owned Subsidiary investment picks
http://media.marketwire.com/attachments/201411/291217_CellMedX_WhiteLogo_Small_FINAL.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1161566&ProfileId=051205&sourceType=1 LAS VEGAS, NV --
Sign-up for Cell MedX Corp. (CMXC), Announces Acquisition of Proprietary Technology for Treatment of Diabetes and Related Ailments investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0978017001&sourceType=1 http://media3.marketwire.com/docs/Cell%20MedX%20Large.jpg LAS VEGAS, NEVADA --
Sign-up for Cell MedX Corp. (CMXC), Announces the formation of an Advisory Board with John Sanderson MD as Chairman investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0978017002&sourceType=1 http://media3.marketwire.com/docs/Cell%20MedX%20Large.jpg LAS VEGAS, NEVADA --
Sign-up for Cell MedX Corp. (CMXC), Announces the formation of an Advisory Board with John Sanderson MD as Chairman investment picks
SAN DIEGO, Dec.
Sign-up for Celladon Corporation Added to NASDAQ Biotechnology Index investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Celebrity Chef Carla Hall to Host $1 Million 47th Pillsbury Bake-Off® Contest to Celladon Corporation Conducts Initial Scale Up of Manufacturing Process for MYDICAR to Commercial Scale
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent